Dysregulated inflammatory mediators and microbial products, such as cytokines (e.g., TNF, IFN, IL-1, IL-22) and endotoxins, are closely linked to barrier dysfunction and impaired intestinal homeostasis [10]
Prior to Schachts study, at least four clinical trials have touched on GLP-1s and alcohol use
For GH secretion studies requiring repeated dosing in in vivo rodent models, Bacteriostatic Water reconstitution of GH secretagogue peptides enables multi-day experimental protocols from a single reconstituted vial without the sterility risk associated with multiple entries into unpreserved aqueous solutions
A large percentage of patients eventually discontinue injectable obesity medications because of cost, tolerability, supply, injection fatigue, or access barriers
other GLP-1 medications may have different recommendations (check the specific product SmPC)
IV glutathione helps control inflammation by neutralizing free radicals and reducing oxidative stress